Header Logo
Keywords
Last Name
Institution
Announcement

You can now add alternative names! Click here to add other names that you've published under.
 Back to Profile

Donald Bodenner

Concepts (247)

Concept scores are derived automatically based on a person's publications. Keywords in the their attributed publications are matched to keywords from the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). The strength of a person's concept scores is based not only on the number of corresponding publications, but also how relevant the concepts are to the overall topics of the publications, how long ago the publications were written, whether the person was the first or senior author, and how many other people have written about the topic.Concepts cannot be directly edited. You can help ensure your concepts are accurate by making sure your attributed publications are correct and up-to-date. We recommend checking over your attributed publications list every three to four months.

Cloud
Categories
Timeline
Details
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Thyroid Neoplasms
14
2017
113
1.910
 Why?
Thyroidectomy
13
2019
61
1.750
 Why?
Parathyroidectomy
8
2018
46
1.240
 Why?
Thyroid Diseases
6
2019
27
1.190
 Why?
Parathyroid Neoplasms
5
2015
25
1.050
 Why?
Thyroid Gland
7
2017
77
0.990
 Why?
Parathyroid Hormone
8
2019
149
0.920
 Why?
Adenoma
4
2017
112
0.920
 Why?
Vitamin D Deficiency
5
2019
46
0.910
 Why?
Vitamin D
4
2015
90
0.780
 Why?
Fluorodeoxyglucose F18
6
2013
181
0.720
 Why?
Positron-Emission Tomography
7
2013
297
0.690
 Why?
Radiopharmaceuticals
7
2015
199
0.680
 Why?
Carcinoma, Papillary
4
2017
50
0.680
 Why?
Ambulatory Surgical Procedures
4
2014
52
0.660
 Why?
Hyperparathyroidism, Primary
4
2018
34
0.630
 Why?
Hyperparathyroidism
2
2015
30
0.570
 Why?
Iodine Radioisotopes
3
2015
34
0.540
 Why?
Megestrol Acetate
2
2007
17
0.510
 Why?
Parathyroid Diseases
2
2016
5
0.500
 Why?
Bone Density Conservation Agents
2
2007
75
0.490
 Why?
Nursing Homes
2
2007
108
0.490
 Why?
Incidental Findings
3
2013
41
0.460
 Why?
Proton Pump Inhibitors
1
2015
86
0.450
 Why?
Diphosphonates
1
2015
92
0.450
 Why?
Academic Medical Centers
2
2012
147
0.440
 Why?
Thyroglobulin
2
2013
7
0.430
 Why?
Parathyroid Glands
5
2018
19
0.410
 Why?
Aged
19
2017
10142
0.410
 Why?
Carcinoma, Medullary
2
2010
12
0.410
 Why?
Middle Aged
25
2017
13028
0.400
 Why?
Hypothyroidism
2
2011
57
0.370
 Why?
Male
31
2019
26652
0.370
 Why?
Retrospective Studies
14
2019
6610
0.360
 Why?
Postoperative Complications
5
2018
1071
0.350
 Why?
Calcitonin
2
2010
30
0.350
 Why?
Humans
44
2019
52114
0.330
 Why?
Carcinoma
2
2012
136
0.330
 Why?
Algorithms
1
2013
663
0.320
 Why?
Thyroid Nodule
3
2017
31
0.310
 Why?
Female
29
2019
28055
0.300
 Why?
Weight Loss
2
2009
256
0.290
 Why?
Appetite Stimulants
1
2007
5
0.270
 Why?
Cachexia
1
2007
28
0.260
 Why?
Aged, 80 and over
9
2017
3382
0.260
 Why?
Teriparatide
1
2007
10
0.260
 Why?
Four-Dimensional Computed Tomography
2
2017
28
0.250
 Why?
Calcium
3
2018
372
0.240
 Why?
Hypocalcemia
2
2016
13
0.240
 Why?
Pituitary Hormones, Anterior
1
2005
4
0.240
 Why?
Hormones
1
2005
59
0.230
 Why?
Phenylurea Compounds
2
2015
18
0.230
 Why?
Osteoporosis
1
2007
160
0.230
 Why?
Quinolines
2
2015
43
0.230
 Why?
Transcriptional Activation
1
2005
128
0.230
 Why?
Pituitary Gland
1
2005
87
0.220
 Why?
Receptors, Estrogen
1
2005
131
0.220
 Why?
Interleukin-6
1
2005
274
0.210
 Why?
NF-kappa B
1
2005
329
0.210
 Why?
Biopsy, Fine-Needle
5
2011
104
0.200
 Why?
Protein Kinase Inhibitors
2
2015
225
0.200
 Why?
Illinois
2
2013
11
0.200
 Why?
Treatment Outcome
8
2015
5456
0.190
 Why?
Adult
13
2017
14095
0.180
 Why?
Gene Expression Regulation
1
2005
1000
0.170
 Why?
Aging
1
2005
701
0.170
 Why?
Young Adult
7
2015
4307
0.160
 Why?
Follow-Up Studies
3
2013
2282
0.160
 Why?
Hyperparathyroidism, Secondary
1
2019
4
0.150
 Why?
Postoperative Period
3
2015
170
0.150
 Why?
Preoperative Care
2
2018
174
0.140
 Why?
Vitamins
2
2018
65
0.140
 Why?
Patient Discharge
3
2016
322
0.140
 Why?
Intraoperative Complications
1
2019
113
0.140
 Why?
Insulin Resistance
2
2009
279
0.130
 Why?
Prospective Studies
2
2013
2424
0.130
 Why?
United States
5
2015
5168
0.130
 Why?
Antineoplastic Agents
2
2015
1214
0.130
 Why?
Predictive Value of Tests
3
2015
939
0.130
 Why?
Reoperation
1
2018
463
0.120
 Why?
Incidence
2
2011
1070
0.120
 Why?
Adolescent
5
2015
6681
0.120
 Why?
Hypoparathyroidism
1
2015
5
0.120
 Why?
Carcinoma, Neuroendocrine
1
2015
25
0.120
 Why?
Creatinine
1
2015
158
0.120
 Why?
Lymph Nodes
1
2017
252
0.120
 Why?
Tomography, Emission-Computed, Single-Photon
1
2015
52
0.110
 Why?
Costs and Cost Analysis
2
2014
95
0.110
 Why?
Disease Progression
3
2015
866
0.110
 Why?
Diagnosis, Differential
6
2018
1031
0.110
 Why?
Molecular Targeted Therapy
1
2015
132
0.110
 Why?
Ambulatory Care
1
2016
239
0.110
 Why?
Neoplasm Metastasis
2
2015
236
0.110
 Why?
Hospitals, University
1
2014
74
0.110
 Why?
Child, Preschool
2
2013
4001
0.100
 Why?
Sensitivity and Specificity
2
2013
871
0.100
 Why?
Liver
2
2009
1154
0.100
 Why?
Exercise
2
2009
552
0.100
 Why?
Drug Administration Schedule
1
2013
374
0.100
 Why?
Hospitals, Teaching
1
2013
52
0.100
 Why?
Technetium
1
2012
8
0.100
 Why?
Preoperative Period
1
2012
47
0.100
 Why?
Administration, Oral
1
2013
453
0.100
 Why?
Clinical Competence
2
2018
396
0.100
 Why?
Radionuclide Imaging
1
2012
104
0.090
 Why?
Patient Compliance
1
2013
229
0.090
 Why?
Outpatients
1
2013
125
0.090
 Why?
Hospital Charges
1
2012
47
0.090
 Why?
Tumor Burden
1
2012
133
0.090
 Why?
Struma Ovarii
1
2012
5
0.090
 Why?
Cost Savings
1
2012
58
0.090
 Why?
Prognosis
3
2015
2093
0.090
 Why?
Child
3
2013
7147
0.090
 Why?
Ovariectomy
1
2012
113
0.090
 Why?
Immunohistochemistry
2
2012
975
0.090
 Why?
Obesity
2
2009
1183
0.080
 Why?
Chromogranin A
1
2010
5
0.080
 Why?
Dose-Response Relationship, Drug
1
2013
1368
0.080
 Why?
Radiation Monitoring
1
2010
7
0.080
 Why?
Inpatients
1
2011
206
0.080
 Why?
Radiosurgery
1
2011
129
0.080
 Why?
Checklist
1
2010
40
0.080
 Why?
Fatal Outcome
1
2010
192
0.080
 Why?
Databases, Factual
1
2013
714
0.080
 Why?
Multiple Endocrine Neoplasia Type 2a
1
2009
5
0.080
 Why?
Caloric Restriction
1
2009
39
0.080
 Why?
Ultrasonography
4
2015
420
0.080
 Why?
Intra-Abdominal Fat
1
2009
21
0.070
 Why?
Proto-Oncogene Proteins c-ret
1
2009
33
0.070
 Why?
General Surgery
1
2010
105
0.070
 Why?
Occupational Exposure
1
2010
109
0.070
 Why?
Blastomycosis
1
2008
30
0.070
 Why?
Receptors, Thyrotropin
1
2007
6
0.070
 Why?
Symporters
1
2007
15
0.070
 Why?
Time Factors
3
2015
2970
0.070
 Why?
Adenoma, Oxyphilic
1
2007
11
0.070
 Why?
Ovarian Neoplasms
1
2012
458
0.070
 Why?
Whole Body Imaging
1
2007
25
0.070
 Why?
Anorexia
1
2007
7
0.070
 Why?
Severity of Illness Index
1
2011
1035
0.070
 Why?
Adiposity
1
2009
143
0.070
 Why?
DNA, Neoplasm
1
2007
146
0.070
 Why?
Calcifediol
1
2006
8
0.060
 Why?
Promoter Regions, Genetic
2
2007
465
0.060
 Why?
Practice Management, Medical
1
2006
9
0.060
 Why?
Calcium Carbonate
1
2006
11
0.060
 Why?
Medical Audit
1
2006
20
0.060
 Why?
Drug Utilization Review
1
2006
22
0.060
 Why?
Drug Monitoring
1
2006
82
0.060
 Why?
Cross-Sectional Studies
2
2014
1665
0.060
 Why?
Head
1
2006
70
0.060
 Why?
Geriatrics
1
2006
41
0.060
 Why?
Gene Expression Regulation, Neoplastic
1
2010
853
0.060
 Why?
Otolaryngology
1
2006
61
0.060
 Why?
Body Mass Index
2
2009
699
0.060
 Why?
Neck
1
2006
98
0.060
 Why?
Proportional Hazards Models
1
2007
439
0.060
 Why?
Progesterone Congeners
1
2005
5
0.060
 Why?
Body Fat Distribution
1
2005
10
0.060
 Why?
Freezing
1
2005
15
0.060
 Why?
Faculty, Medical
1
2006
89
0.060
 Why?
Arkansas
2
2014
2016
0.060
 Why?
Fractures, Bone
1
2006
104
0.060
 Why?
Serum
1
2005
32
0.060
 Why?
Survival Analysis
1
2007
667
0.060
 Why?
DNA Primers
1
2005
204
0.060
 Why?
Reproducibility of Results
3
2017
1214
0.060
 Why?
Internship and Residency
1
2010
433
0.060
 Why?
HeLa Cells
1
2005
242
0.060
 Why?
Base Sequence
1
2005
627
0.050
 Why?
Nuclear Proteins
1
2005
246
0.050
 Why?
Infant
1
2012
3660
0.050
 Why?
Protein Binding
1
2005
665
0.050
 Why?
ROC Curve
2
2015
250
0.050
 Why?
Patient Selection
2
2018
265
0.050
 Why?
Intraoperative Period
2
2015
46
0.050
 Why?
Randomized Controlled Trials as Topic
1
2005
608
0.050
 Why?
Tomography, X-Ray Computed
3
2012
1148
0.040
 Why?
Thalidomide
1
2002
377
0.040
 Why?
Glucagon
2
2009
24
0.040
 Why?
Cohort Studies
2
2015
1541
0.040
 Why?
Monitoring, Intraoperative
1
2019
52
0.040
 Why?
Cholecalciferol
1
2018
22
0.040
 Why?
Hospitals, High-Volume
1
2018
25
0.040
 Why?
Medical History Taking
1
2018
46
0.040
 Why?
Risk Factors
1
2006
3922
0.030
 Why?
Pilot Projects
2
2010
712
0.030
 Why?
Methylene Blue
1
2017
7
0.030
 Why?
Lymphatic System
1
2017
13
0.030
 Why?
Societies, Medical
1
2018
200
0.030
 Why?
Animals, Genetically Modified
1
2017
52
0.030
 Why?
Coloring Agents
1
2017
68
0.030
 Why?
Mice, Inbred Strains
1
2017
163
0.030
 Why?
Proto-Oncogene Proteins B-raf
1
2017
77
0.030
 Why?
Insulin
2
2009
484
0.030
 Why?
Recurrence
1
2018
680
0.030
 Why?
Lymphatic Metastasis
1
2017
210
0.030
 Why?
Bone Density
1
2018
394
0.030
 Why?
Technetium Tc 99m Sestamibi
1
2015
17
0.030
 Why?
Retreatment
1
2015
58
0.030
 Why?
Brachial Plexus
1
2015
12
0.030
 Why?
Endocrinology
1
2015
11
0.030
 Why?
Axilla
1
2015
92
0.030
 Why?
Hematoma
1
2015
67
0.030
 Why?
Transplantation, Autologous
1
2015
480
0.030
 Why?
Neoplasm Staging
1
2015
766
0.020
 Why?
Hernia, Abdominal
1
2012
4
0.020
 Why?
Activating Transcription Factor 1
1
2012
22
0.020
 Why?
Delayed Diagnosis
1
2012
29
0.020
 Why?
Mutation
1
2017
1318
0.020
 Why?
Ribs
1
2010
16
0.020
 Why?
Thoracotomy
1
2010
33
0.020
 Why?
Neck Dissection
1
2010
29
0.020
 Why?
Mediastinal Neoplasms
1
2010
18
0.020
 Why?
Hypercalcemia
1
2010
34
0.020
 Why?
Feasibility Studies
1
2011
399
0.020
 Why?
Gas Chromatography-Mass Spectrometry
1
2009
70
0.020
 Why?
Octreotide
1
2009
9
0.020
 Why?
Hospitalization
1
2014
739
0.020
 Why?
Prevalence
1
2012
1013
0.020
 Why?
Glucose Tolerance Test
1
2009
61
0.020
 Why?
Adiponectin
1
2009
46
0.020
 Why?
Enzyme-Linked Immunosorbent Assay
1
2009
234
0.020
 Why?
Postmenopause
1
2009
83
0.020
 Why?
Absorptiometry, Photon
1
2009
159
0.020
 Why?
Eye
1
2008
25
0.020
 Why?
Bone Neoplasms
1
2010
184
0.020
 Why?
Iodine
1
2007
12
0.020
 Why?
Multiple Myeloma
1
2002
2999
0.020
 Why?
Neoplasm Recurrence, Local
1
2011
630
0.020
 Why?
Methylation
1
2007
126
0.020
 Why?
Body Weight
1
2009
526
0.020
 Why?
Overweight
1
2009
230
0.020
 Why?
Current Procedural Terminology
1
2006
10
0.020
 Why?
Insurance, Health, Reimbursement
1
2006
24
0.020
 Why?
Mice
1
2017
5877
0.020
 Why?
Office Visits
1
2006
44
0.020
 Why?
Polymerase Chain Reaction
1
2007
460
0.020
 Why?
Genetic Predisposition to Disease
1
2009
528
0.020
 Why?
Blood Glucose
1
2009
475
0.020
 Why?
Risk Assessment
1
2010
1339
0.010
 Why?
Lung
1
2008
488
0.010
 Why?
Muscle, Skeletal
1
2009
808
0.010
 Why?
Thyroid Function Tests
1
2002
27
0.010
 Why?
Animals
1
2017
13332
0.010
 Why?
Thyrotropin
1
2002
49
0.010
 Why?
Clinical Trials as Topic
1
2002
463
0.010
 Why?
Bodenner's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
See all (247) concept(s)
_
Co-Authors Expand Description
See all (16) people
_
Similar People Expand Description
See all (32) people
_
Same Department Expand Description
Search Department